ENT Liu Knowledge Base Head & neck tumours · physician reviewed
Oral Potentially Malignant Disorders · Prevention & risk

Does stopping betel quid and areca nut really lower my risk?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Oral Potentially Malignant Disorders Answer length: short, citable
Quick answer

Yes. Areca nut and betel quid (with or without tobacco) are IARC Group 1 carcinogens, and continued exposure is the main driver of both oral submucous fibrosis progression and malignant transformation. Risk falls over time after cessation, although it does not return immediately to that of a never-user, so surveillance should continue.

In detail

Areca nut is addictive, and arecoline produces dependence, so behavioural support and, where tobacco is involved, standard tobacco-cessation pharmacotherapy are appropriate. Tell your dentist or doctor explicitly what you chew — many patients do not consider it "tobacco".

What this means in practice: this answer is part of the “Prevention & risk” section of the Oral Potentially Malignant Disorders topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about oral potentially malignant disorders

See all 13 questions in this topic →

Sources for this answer

  1. Smokeless Tobacco and Oral Cancer in Global Perspective New England Journal of Medicine · 2026 · More than 360 million users of smokeless tobacco; ~120,000 oral cancer cases attributable to smokeless tobacco, areca nut or both in 2022.
  2. IARC Monographs on the Identification of Carcinogenic Hazards to Humans (tobacco, areca nut, UV radiation, EBV, HPV) International Agency for Research on Cancer / WHO · 2024

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

← Previous questionWill an oral white patch turn into cancer? Next question →Is oral cancer screening worthwhile for people who chew tobacco?

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.